Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             85 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Addendum 2006
8 p. 1268
artikel
2 Air swallowing, belching, acid and non-acid reflux in patients with functional dyspepsia CONCHILLO, J. M.
2007
8 p. 965-971
artikel
3 Altered intestinal permeability is predictive of early relapse in children with steroid-responsive ulcerative colitis MIELE, E.
2007
8 p. 933-939
artikel
4 Antibiotic prophylaxis for percutaneous endoscopic gastrostomy insertion in patients with non-malignant disease R obins, G.
2006
8 p. 1276-1277
artikel
5 Antibiotic prophylaxis for percutaneous endoscopic gastrostomy insertion in patients with non-malignant disease: authors' reply F isher, N. C.
2006
8 p. 1277
artikel
6 Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin PRANTERA, C.
2006
8 p. 1117-1125
artikel
7 A prospective 1-year follow-up study in patients with functional or organic dyspepsia: changes in gastrointestinal symptoms, mental distress and fear of serious illness PAJALA, M.
2006
8 p. 1241-1246
artikel
8 Assessing patients’ understanding of hepatitis C virus infection and its impact on their lifestyle FABRIS, P.
2006
8 p. 1161-1170
artikel
9 Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study DI MARIO, F.
2006
8 p. 1235-1240
artikel
10 CagA status and successful eradication of Helicobacter pylori T reiber, G.
2006
8 p. 1261-1263
artikel
11 CagA status and successful eradication of Helicobacter pylori: authors’ reply M atsuo, K.
2006
8 p. 1263
artikel
12 Clinical trial: an efficacy evaluation of reduced bisacodyl given as part of a polyethylene glycol electrolyte solution preparation prior to colonoscopy DIPALMA, J. A.
2007
8 p. 1113-1119
artikel
13 Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis – a randomized, multicentre, placebo-controlled study MCCALLUM, R. W.
2007
8 p. 1121-1130
artikel
14 Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy – a randomized study comparing ranitidine with esomeprazole GOLDSTEIN, J. L.
2007
8 p. 1101-1111
artikel
15 Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid AZZAROLI, F.
2007
8 p. 1139-1146
artikel
16 Clinical trial: pharmacodynamics and pharmacokinetics of re-treatment with fixed-dose induction of peginterferon α-2a in hepatitis C virus genotype 1 true non-responder patients DIAGO, M.
2007
8 p. 1131-1138
artikel
17 Comparison of the effects of fasting morning, fasting evening and fed bedtime administration of tenatoprazole on intragastric pH in healthy volunteers: a randomized three-way crossover study THOMSON, A. B. R.
2006
8 p. 1179-1187
artikel
18 Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study SIMON-RUDLER, M.
2007
8 p. 949-954
artikel
19 Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident ABRAHAM, N. S.
2007
8 p. 913-924
artikel
20 Double stenting of oesophagus and airways in palliative treatment of patients with oesophageal cancer is efficient but associated with a high morbidity LECLEIRE, S.
2007
8 p. 955-963
artikel
21 Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic DE VALLE, M. B.
2006
8 p. 1187-1195
artikel
22 Early changes in rectal nitric oxide and mucosal inflammatory mediators in Crohn’s colitis in response to infliximab treatment LJUNG, T.
2007
8 p. 925-932
artikel
23 Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B CHAN, H. L.-Y.
2007
8 p. 891-898
artikel
24 Effect of anti-viral therapy for occult hepatitis C virus infection PARDO, M.
2006
8 p. 1153-1159
artikel
25 Effect of intravenous infusion of glyceryl trinitrate on gastric and small intestinal motor function in healthy humans MADSEN, J. L.
2006
8 p. 1251-1257
artikel
26 Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection VENERITO, M.
2006
8 p. 1225-1233
artikel
27 Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial LAINÉ, F.
2006
8 p. 1207-1213
artikel
28 Endosonography- vs. endoscopic retrograde cholangiopancreatography-based strategies in the evaluation of suspected common bile duct stones in patients with normal transabdominal imaging ANG, T. L.
2007
8 p. 1163-1170
artikel
29 Errata / Corrigenda 2007
8 p. 1002
artikel
30 Errata / Corrigenda 2007
8 p. 1002
artikel
31 Errata / Corrigenda 2007
8 p. 1001-1002
artikel
32 Errata / Corrigenda 2007
8 p. 1002
artikel
33 Erratum 2006
8 p. 1268
artikel
34 GI Epidemiology: nonalcoholic fatty liver disease ANGULO, P.
2007
8 p. 883-889
artikel
35 Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis C CASTERA, L.
2006
8 p. 1223-1230
artikel
36 Impracticalities of thiopurine S-methyltransferase determination in daily inflammatory bowel disease practice B oer, N. K. H.
2006
8 p. 1278-1279
artikel
37 Impracticalities of thiopurine-S-methyltransferase determination in daily inflammatory bowel disease practice: authors' reply W inter, J.
2006
8 p. 1279-1280
artikel
38 Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole GOLDSTEIN, J. L.
2006
8 p. 1189-1196
artikel
39 Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer CHRISTENSEN, S.
2007
8 p. 907-912
artikel
40 Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? HAAG, S.
2007
8 p. 973-986
artikel
41 Levofloxacin-based rescue regimens after Helicobacter pylori treatment failure: how strong is the evidence? Y uan, Y.
2006
8 p. 1283-1285
artikel
42 Levofloxacin-based rescue regimens after Helicobacter pylori treatment failure: how strong is the evidence? Author's reply G isbert, J. P.
2006
8 p. 1285-1286
artikel
43 Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study SANDS, B. E.
2006
8 p. 1127-1136
artikel
44 Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease CANAVAN, C.
2006
8 p. 1097-1104
artikel
45 Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children SZAJEWSKA, H.
2007
8 p. 871-881
artikel
46 Meta-analysis: mortality in Crohn’s disease CANAVAN, C.
2007
8 p. 861-870
artikel
47 Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population FABRIZI, F.
2006
8 p. 1105-1112
artikel
48 Meta-analysis: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories CAPURSO, G.
2007
8 p. 1089-1099
artikel
49 Motor disturbances participate in the pathogenesis of eosinophilic oesophagitis, beyond the fibrous remodelling of the oesophagus L ucendo, A. J.
2006
8 p. 1264-1267
artikel
50 Oesophagitis is common in patients with achalasia after pneumatic dilatation LEEUWENBURGH, I.
2006
8 p. 1197-1203
artikel
51 Pancreatic cancer in England and Wales 1975–2000: patterns and trends in incidence, survival and mortality WOOD, H. E.
2006
8 p. 1205-1214
artikel
52 Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis MIYAKE, Y.
2006
8 p. 1197-1205
artikel
53 Personal view: a potential novel treatment for fatigue complicating chronic liver disease – how should its efficacy be evaluated? JONES, E. A.
2006
8 p. 1113-1116
artikel
54 Pharmacogenetics of thiopurine therapy in paediatric IBD patients RIDDER, L.
2006
8 p. 1137-1141
artikel
55 Polyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: a randomized-controlled clinical trial RENDELI, C.
2006
8 p. 1259-1265
artikel
56 Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding KEYVANI, L.
2006
8 p. 1247-1255
artikel
57 Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease WONG, V. W. S.
2006
8 p. 1215-1222
artikel
58 Prokinetic effect of gut-oriented hypnosis on gastric emptying CHIARIONI, G.
2006
8 p. 1241-1249
artikel
59 Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study CAPANNI, M.
2006
8 p. 1143-1151
artikel
60 Prospective randomized trial evaluating ketamine for advanced endoscopic procedures in difficult to sedate patients VARADARAJULU, S.
2007
8 p. 987-997
artikel
61 Proton pump inhibitor failure in gastro-oesophageal reflux disease – what about eosinophilic oesophagitis? S gouros, S. N.
2006
8 p. 1281
artikel
62 Proton pump inhibitor failure in gastro-oesophagel reflux disease – what about eosinophilic oesophagitis? Authors’ reply F ass, R.
2006
8 p. 1282-1283
artikel
63 Rebound acid hypersecretion F ossmark, R.
2007
8 p. 999-1000
artikel
64 Rebound acid hypersecretion: author's reply H unfeld, N. G. M.
2007
8 p. 1000
artikel
65 Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives McMAHON, B. J.
2006
8 p. 1215-1223
artikel
66 Review article: alcoholic liver disease – pathophysiological aspects and risk factors GRAMENZI, A.
2006
8 p. 1151-1161
artikel
67 Review article: hepatitis B and liver transplantation MUTIMER, D.
2006
8 p. 1031-1041
artikel
68 Review article: immune suppression and colorectal cancer EVANS, C.
2006
8 p. 1163-1177
artikel
69 Review article: intestinal serotonin signalling in irritable bowel syndrome MAWE, G. M.
2006
8 p. 1067-1076
artikel
70 Review article: management of patients with chronic hepatitis C virus infection and ‘normal’ alanine aminotransferase activity ZEUZEM, S.
2006
8 p. 1133-1149
artikel
71 Review article: predicting response in hepatitis C virus therapy MIHM, U.
2006
8 p. 1043-1054
artikel
72 Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options GIANNINI, E. G.
2006
8 p. 1055-1065
artikel
73 Serum bilirubin and risk of colorectal cancer Z ucker, S. D.
2006
8 p. 1257-1259
artikel
74 Serum bilirubin and risk of colorectal cancer: authors’ reply I oannou, G. N.
2006
8 p. 1259-1261
artikel
75 Survival and dependence on home parenteral nutrition: experience over a 25-year period in a UK referral centre LLOYD, D. A. J.
2006
8 p. 1231-1240
artikel
76 Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? GOTTELAND, M.
2006
8 p. 1077-1086
artikel
77 The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy – a decision analysis HUANG, E.
2007
8 p. 1147-1161
artikel
78 The usefulness of transabdominal ultrasound for the diagnosis of lower gastrointestinal bleeding YAMAGUCHI, T.
2006
8 p. 1267-1272
artikel
79 Thiopurine metabolite monitoring in paediatric inflammatory bowel disease OOI, C. Y.
2007
8 p. 941-947
artikel
80 Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study YUEN, M.-F.
2006
8 p. 1179-1186
artikel
81 Treatment of anaemia in inflammatory bowel disease K outroubakis, I. E.
2006
8 p. 1273-1274
artikel
82 Treatment of anaemia in inflammatory bowel disease: authors’ reply S ilva, A.
2006
8 p. 1274-1275
artikel
83 Treatment of chronic he1patitis C genotype 1 with peginterferon- α2a (40 kDa) plus ribavirin under routine clinical practice in Spain: early prediction of sustained virological response rate DIAGO, M.
2007
8 p. 899-906
artikel
84 Upper gastrointestinal bleeding and the changing use of COX-2 non-steroidal anti-inflammatory drugs and low-dose aspirin TAHA, A. S.
2007
8 p. 1171-1178
artikel
85 48 weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection HUI, C.-K.
2006
8 p. 1171-1178
artikel
                             85 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland